Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
2.390
-0.080 (-3.24%)
At close: Dec 5, 2025, 4:00 PM EST
2.380
-0.010 (-0.42%)
After-hours: Dec 5, 2025, 7:34 PM EST
Tharimmune Market Cap
Tharimmune has a market cap or net worth of $83.76 million as of December 5, 2025. Its market cap has increased by 2,278.17% in one year.
Market Cap
83.76M
Enterprise Value
76.34M
1-Year Change
2,278.17%
Ranking
Category
Stock Price
$2.39
Market Cap Chart
Since the IPO on January 12, 2022, Tharimmune's market cap has increased from $41.18M to $83.76M, an increase of 103.39%. That is a compound annual growth rate of 19.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 86.56M | 2,105.08% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -89.09% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 899.50B |
| Johnson & Johnson | 486.85B |
| AbbVie | 400.17B |
| UnitedHealth Group | 299.32B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 248.24B |
| Abbott Laboratories | 217.34B |